<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.

Neuro Therapies

INS 2022 Interview with Dr. Marc Russo: Dorsal Horn Dendrite Stimulation for SCS

Dr. Marc Russo discusses dorsal horn dendrite stimulation, a new paradigm for SCS, and making it availab...

Neuro Therapies

What’s New in Neuromodulation for Spring 2022

In the market for neuromodulation, companies are developing spinal cord stimulation (SCS), deep brain st...

Neuro Therapies

Wallaby Acquires phenox GmBH

Wallaby Medical announced it has acquired phenox GmbH, including phenox's femtos GmbH, a German-based ne...

Neuro Therapies

Abbott: Expanding the Ecosystem in DBS - An Interview with Binith Cheeran

Abbott’s Binith Cheeran, MD, PhD discusses the latest trends in DBS as well as the Company’s strategies ...

Losing Steam Due to COVID: Q421/FY21 Spinal Cord Stimulation Market Recap

Spinal Cord Stimulation companies had a strong start in Q421 but the market lost steam as the Omicron va...

Neuro Therapies

NANS 2022: What's New for Abbott Neuromodulation

Abbott’s Allen Burton, MD discusses the Company’s new MRI labeling, expanded payer coverage for DRG, big...

Neuro Therapies

Medtronic: The Future of Neuromodulation in 2022 and Beyond

Medtronic Neuromodulation executives Dave Anderson and Charlie Covert discuss the Company and the future...

Neuro Therapies

An Interview with Nevro's D. Keith Grossman

D. Keith Grossman, chairman, CEO and president of Nevro Corporation, discusses the Company, expanding in...

Neuro Therapies

SCS Boomerangs Back: Q221 Market Report

A big boost in Q2 with double-digit gains in all segments. The US and WW SCS Market boomeranged to pre-C...

Neuro Therapies

An Interview with Medtronic's Brett Wall

Brett Wall, EVP and President of Medtronic’s Neuroscience Portfolio, discusses changes and opportunities...

1
...
4 5 6
...
12